MedTrace Logo

Smartphone Flicker Fusion Test for Patients With Optic Disorders.

NCT03475147 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-11-24

No results posted yet for this study

Summary

The purpose of this project is to validate a quick, easy-to-use and administer smartphone flicker fusion test. The app (called eyeFusion) can potentially be used to easily and quickly collect critical flicker fusion measurements on patients admitted with optic disorders as part of the clinical care process.

Conditions

  • Scotoma

Interventions

DEVICE

eyeFusion

Smartphone app based flicker fusion test.

Sponsors & Collaborators

  • Randy Kardon

    lead OTHER

Principal Investigators

  • Randy Kardon, MD, PhD · University of Iowa

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-27
Primary Completion
2028-01-01
Completion
2028-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03475147 on ClinicalTrials.gov